These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 27426632)

  • 1. A case of first-onset psychosis and repeated relapses secondary to discontinuation of non-prescription estrogen replacement therapy in a transgendered female.
    Moffitt O; Findley JC
    Gynecol Endocrinol; 2016 Oct; 32(10):796-798. PubMed ID: 27426632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case of repeated brief psychotic episodes secondary to discontinuation of non-prescription estrogen replacement therapy.
    Findley JC; Joshi KG
    Psychosomatics; 2012; 53(3):285-8. PubMed ID: 22305488
    [No Abstract]   [Full Text] [Related]  

  • 3. A syndrome of psychosis following discontinuation of an estrogen-progestogen contraceptive and improvement following replacement: A case report.
    Huber TJ; Nickel V; Tröger M; Schneider U; Husstedt H; Emrich HM
    Neuropsychobiology; 1999; 40(2):75-7. PubMed ID: 10474061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-ovariectomy and oestrogen therapy related recurrence of oestrogen withdrawal associated psychosis.
    Chandra PS
    Acta Psychiatr Scand; 2002 Jul; 106(1):76; author reply 76-7. PubMed ID: 12100352
    [No Abstract]   [Full Text] [Related]  

  • 5. A case of repeated mixed mood episodes with psychotic symptoms associated with the premenstrual period in a patient with polycystic ovarian syndrome.
    Jalnapurkar I; Findley JC
    Gynecol Endocrinol; 2018 Jun; 34(6):467-469. PubMed ID: 29166805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-Prescribed Hormone Use and Barriers to Care for Transgender Women in San Francisco.
    de Haan G; Santos GM; Arayasirikul S; Raymond HF
    LGBT Health; 2015 Dec; 2(4):313-23. PubMed ID: 26788772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mature Testicular Teratoma with Positive Estrogen Receptor Beta Expression in a Transgendered Individual on Cross-Sex Hormonal Therapy: A Case Report.
    Kobori Y; Suzuki K; Iwahata T; Shin T; Sato R; Nishio K; Yagi H; Arai G; Soh S; Okada H
    LGBT Health; 2015 Mar; 2(1):81-3. PubMed ID: 26790022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of systemic lupus erythematosus in a male-to-female transsexual: the role of sex hormones revisited.
    Chan KL; Mok CC
    Lupus; 2013 Nov; 22(13):1399-402. PubMed ID: 23897544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen replacement therapy and asthma.
    Ticconi C; Pietropolli A; Piccione E
    Pulm Pharmacol Ther; 2013 Dec; 26(6):617-23. PubMed ID: 24035822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can oestrogen use prevent the onset of psychosis?
    Dhillon R; Bastiampillai T; Mohan T; Khor L
    Aust N Z J Psychiatry; 2013 Jul; 47(7):682-3. PubMed ID: 23439316
    [No Abstract]   [Full Text] [Related]  

  • 11. Melanoma onset after estrogen, thyroid, and growth hormone replacement therapy.
    Caldarola G; Battista C; Pellicano R
    Clin Ther; 2010 Jan; 32(1):57-9. PubMed ID: 20171412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiologic aspects of exogenous progestagens in relation to their role in pathogenesis of human breast cancer.
    van Leeuwen FE
    Acta Endocrinol (Copenh); 1991; 125 Suppl 1():13-26. PubMed ID: 1801500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of hormone replacement therapy on antithrombin III and protein C levels in menopausal women.
    Lacroix KA; Bean C; Reilly R; Curran-Celentano J
    Clin Lab Sci; 1997; 10(3):145-8. PubMed ID: 10167774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Course of cannabis use and clinical outcome in patients with non-affective psychosis: a 3-year follow-up study.
    van der Meer FJ; Velthorst E;
    Psychol Med; 2015 Jul; 45(9):1977-88. PubMed ID: 25654244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Menopause and hormone replacement therapy].
    Tóth KS
    Orv Hetil; 2000 Mar; 141(11):547-56. PubMed ID: 10741167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylactic estrogen in recurrent postpartum affective disorder.
    Sichel DA; Cohen LS; Robertson LM; Ruttenberg A; Rosenbaum JF
    Biol Psychiatry; 1995 Dec; 38(12):814-8. PubMed ID: 8750040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Child loss and psychosis onset: evidence for traumatic experience as an etiological factor in psychosis.
    Devylder JE; Wang JS; Oh HY; Lukens EP
    Psychiatry Res; 2013 Jan; 205(1-2):90-4. PubMed ID: 22939520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transdermal estrogen replacement therapy in postmenopausal women previously treated for porphyria cutanea tarda.
    Bulaj ZJ; Franklin MR; Phillips JD; Miller KL; Bergonia HA; Ajioka RS; Griffen LM; Guinee DJ; Edwards CQ; Kushner JP
    J Lab Clin Med; 2000 Dec; 136(6):482-8. PubMed ID: 11128750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cumulative exposure to estrogen and psychosis: a peak bone mass, case-control study in first-episode psychosis.
    Maric N; Popovic V; Jasovic-Gasic M; Pilipovic N; van Os J
    Schizophr Res; 2005 Mar; 73(2-3):351-5. PubMed ID: 15653281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Psychogenic psychosis].
    Formoso SM; Romero MA
    Actas Esp Psiquiatr; 2007; 35(3):219-20. PubMed ID: 17508299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.